跳至主要内容
临床试验/CTRI/2023/08/056505
CTRI/2023/08/056505尚未招募2 期

Efficacy and Safety of Intranasal Application of Human Milk for Neuroprotection in Neonates with Hypoxic Ischemic Encephalopathy: A Pilot Randomized Controlled Trial - NI

Banaras Hindu University0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Term or post term neonates will be recruited to the trial if they meet both of the following two criteria of eligibility: first, a need for continued resuscitation at 5 min of age or an Apgar score of less than 6 at 5 min of age (for babies born in a hospital), or both, or an absence of crying by 5 min of age (for babies born at home); and second, evidence of encephalopathy based on clinical examination using modified Sarnat staging

排除标准

  • 1. Chromosomal anomalies
  • 2. Major congenital malformation
  • 3. Microcephaly
  • 4. Dysmorphic features
  • 5. Suspected intrauterine infection
  • 6.Failure to obtain consent

研究者

相似试验